First Time Loading...
W

Wockhardt Ltd
NSE:WOCKPHARMA

Watchlist Manager
Wockhardt Ltd
NSE:WOCKPHARMA
Watchlist
Price: 550.05 INR 0.12% Market Closed
Updated: May 15, 2024
Section:
 

Wall Street
Price Targets

WOCKPHARMA Price Targets Summary
Wockhardt Ltd

Wall Street analysts forecast WOCKPHARMA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WOCKPHARMA is 450 INR .

WOCKPHARMA Lowest Forecast
Wall Street Target
Not Available
WOCKPHARMA Average Forecast
Wall Street Target
450 INR
18% Downside
WOCKPHARMA Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
450 INR
18% Downside
Highest
Price Target
Not Available
Wockhardt Ltd Competitors:
Price Targets
N
603538
Ningbo Menovo Pharmaceutical Co Ltd
56% Upside
688185
CanSino Biologics Inc
42% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
28% Upside
N
600812
North China Pharmaceutical Co Ltd
139% Upside
N
603538
Ningbo Menovo Pharmaceutical Co Ltd
56% Upside
688185
CanSino Biologics Inc
42% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
28% Upside
N
600812
North China Pharmaceutical Co Ltd
139% Upside
JAGX
Jaguar Health Inc
125% Upside
J
4015
Jamjoom Pharmaceuticals Factory Company SJSC
6% Downside
600535
Tasly Pharmaceutical Group Co Ltd
8% Downside
T
600867
Tonghua Dongbao Pharmaceutical Co Ltd
43% Upside

Revenue
Forecast

Revenue Estimate
Wockhardt Ltd

For the last 8 years the compound annual growth rate for Wockhardt Ltd's revenue is -6%. The projected CAGR for the next 6 years is 9%.

-6%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Wockhardt Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Wockhardt Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
WOCKPHARMA intrinsic value, competitors valuation, and company profile.
DCF Valuation
WOCKPHARMA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
WOCKPHARMA stock valuation using valuation multiples.
Wall Street Estimates
WOCKPHARMA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
WOCKPHARMA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is WOCKPHARMA's stock price target?
Price Target
450 INR

According to Wall Street analysts, the average 1-year price target for WOCKPHARMA is 450 INR .

What is Wockhardt Ltd's Revenue forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Wockhardt Ltd's revenue is -6%. The projected CAGR for the next 6 years is 9%.

ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.